US FDA approves Amgen's Uplizna as first treatment for rare immune disorder
The U.S. Food and Drug Administration has approved expanded use of Amgen's drug, Uplizna, to help reduce the risk of flares ...
Healio10 分钟
‘Pivotal moment’: Uplizna becomes first FDA-approved treatment for IgG4-related disease
The FDA on Thursday gave the green light to Uplizna in IgG4-related disease, making it the first and only approved treatment ...
Asianet Newsable on MSN1 小时
Amgen Stock Edges Higher After Uplizna Becomes First FDA-Approved Treatment For Immune ...
Shares of medicine manufacturer Amgen Inc (AMGN) are in the spotlight on Friday after it announced that the U.S. Food and ...
The American Journal of Managed Care18 小时
Inebilizumab FDA Approved as First Treatment for IgG4-RD
Inebilizumab-cdon (Uplizna; Amgen) was approved as the first and only treatment for immunoglobulin G4–related disease ...
1AMGN : FDA Approves Amgen's Uplizna As First Drug For Chronic Immune-Mediated...
The FDA approved Amgen's Uplizna as the first treatment for IgG4-RD. The decision is backed by the MITIGATE trial, showing reduced flares and sustained efficacy.
BioSpace3 小时
Amgen Wins Expansion for Uplizna as First Drug for IgG4-Related Disease
The FDA approved Amgen ’s anti-CD19 therapy Uplizna Thursday for use in patients with IgG4-related disease. Uplizna is the ...
STAT1 天
Makary’s first speech to FDA staff focuses on challenging norms, fighting chronic disease
In recording, Makary said little about specific plans for his agency or about the layoffs that have roiled his workforce.
FDA approves first new antibiotic for UTIs in nearly 30 years
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome
The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic disorder, ...
FDA approves first at-home, over-the-counter test for STIs. But there's a catch.
The FDA announced Friday that it had approved the first at-home test for sexually transmitted infections, opening the pathway for more to come.
腾讯网9 天
GSK公司(GSK.US)抗生素Blujepa获FDA批准上市 用于治疗单纯性尿路感染
智通财经APP获悉，GSK(GSK.US)公司今日宣布，美国FDA批准“first-in-class”抗生素Blujepa(gepotidacin)上市，用于治疗单纯性尿路感染(uUTI)的成人及12岁以上青少年患者。作为一款具有全新作用机制的抗生素 ...